France Biotechnology & Medical Research

Oncodesign Precision Medicine Opm SA (ALOPM)

Track

Ticker: ALOPM Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Philippe GENNE Président Directeur-Général Executive Director
Through SAS P.C.G Société par actions simplifiée, a closely affiliated person
Transaction date
Sale
Price
223.62
Quantity 70,631
Value €832,044
Karine LIGNEL Administratrice Director
Transaction date
Purchase
Price
356.46
Quantity 59,994
Value €2,615,701
Philippe GENNE Président Directeur-Général Executive Director
Through SAS P.C.G Société par actions simplifiée, a closely affiliated person
Transaction date
Sale
Price
74.73
Quantity 25,855
Value €3,841,678
Jan HOFLACK Administrateur Director
Transaction date
Purchase
Price
0.82
Quantity 150,000
Value €123,000
PHILIPPE GENNE PRESIDENT DIRECTEUR GENERAL Executive Director
Through P.C.G. société civile, a closely affiliated person
Transaction date
Purchase
Price
0.70
Quantity 167,308
Value €117,116
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-12-19 2022-12-12 S Sale
Philippe GENNE

Président Directeur-Général

Through SAS P.C.G Société par actions simplifiée, a closely affiliated person Executive Director
70,631
223.62
€832,044 		70,631 223.62 €832,044
2022-12-19 2022-12-12 B Purchase
Karine LIGNEL

Administratrice

Director
59,994
356.46
€2,615,701 		59,994 356.46 €2,615,701
2022-12-19 2022-12-08 S Sale
Philippe GENNE

Président Directeur-Général

Through SAS P.C.G Société par actions simplifiée, a closely affiliated person Executive Director
25,855
74.73
€3,841,678 		25,855 74.73 €3,841,678
2022-12-19 2022-12-08 B Purchase
Jan HOFLACK

Administrateur

Director
150,000
0.82
€123,000 		150,000 0.82 €123,000
2022-12-08 2022-10-28 B Purchase
PHILIPPE GENNE

PRESIDENT DIRECTEUR GENERAL

Through P.C.G. société civile, a closely affiliated person Executive Director
167,308
0.70
€117,116 		167,308 0.70 €117,116
Explore more

More insider trading research around Oncodesign Precision Medicine Opm SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe